Heart failure drug test halted early in small kidney study
NCT ID NCT06611423
Summary
This early-stage study aimed to see if a single dose of an experimental drug, AZD3427, could improve blood flow to the kidneys in people who have both heart failure and reduced kidney function. Researchers used special PET scans to measure blood flow in the kidneys before and after treatment. The study was terminated early and only enrolled 10 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Solna, 171 64, Sweden
Conditions
Explore the condition pages connected to this study.